We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$36.7B
AUM Growth
+$5.6B
(+18%)
Cap. Flow
+$3.46B
Cap. Flow
% of AUM
9.43%
Top 10 Holdings %
Top 10 Hldgs %
25.01%
Holding
1,178
New
48
Increased
837
Reduced
168
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$236M |
| 2 |
Apple
AAPL
|
+$178M |
| 3 |
PayPal
PYPL
|
+$97.4M |
| 4 |
Amazon
AMZN
|
+$90.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$45.4M |
| 2 |
Fidelity National Information Services
FIS
|
+$39.2M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$20.6M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$18.1M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$8.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.26% |
| 2 | Healthcare | 19.27% |
| 3 | Financials | 13.41% |
| 4 | Consumer Staples | 8.81% |
| 5 | Industrials | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
4D Molecular Therapeutics
FDMT
$594M
| $248K | ﹤0.01% |
+12,036
| New | +$186K |
|
1002
Codexis
CDXS
$162M
| $245K | ﹤0.01% |
52,389
+28,704
| +121% | +$157K |
|
1003
Iovance Biotherapeutics
IOVA
$2.89B
| $244K | ﹤0.01% |
40,015
+23,090
| +136% | +$180K |
|
|
MRUS
1004
DELISTED
Merus
MRUS
| $240K | ﹤0.01% |
15,372
-159
| -1% | -$2.8K |
|
1005
Maravai LifeSciences
MRVI
$881M
| $238K | ﹤0.01% |
17,370
+9,765
| +128% | +$154K |
|
1006
Xencor
XNCR
$1.64B
| $236K | ﹤0.01% |
9,107
-1,870
| -17% | -$52.3K |
|
1007
Vir Biotechnology
VIR
$1.51B
| $232K | ﹤0.01% |
9,302
-641
| -6% | -$15.7K |
|
1008
Immersion
IMMR
$253M
| $232K | ﹤0.01% |
30,615
-13,076
| -30% | -$84.2K |
|
1009
BioNTech
BNTX
$23.2B
| $225K | ﹤0.01% |
1,511
+25
| +2% | +$3.85K |
|
|
ONL
1010
Orion Office REIT
ONL
$157M
| $224K | ﹤0.01% |
26,819
| – | – |
|
|
NVO
1011
Novo Nordisk
NVO
$206B
| $222K | ﹤0.01% |
3,244
-300
| -8% | -$17.6K |
|
|
SGMO
1012
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $219K | ﹤0.01% |
69,610
+7,906
| +13% | +$30.7K |
|
|
OLP
1013
One Liberty Properties
OLP
$515M
| $217K | ﹤0.01% |
9,618
+2,724
| +40% | +$62.4K |
|
1014
dLocal
DLO
$4.13B
| $211K | ﹤0.01% |
13,706
+7,346
| +116% | +$129K |
|
1015
Vontier
VNT
$4.63B
| $207K | ﹤0.01% |
10,560
| – | – |
|
1016
Atara Biotherapeutics
ATRA
$79.6M
| $203K | ﹤0.01% |
2,480
+522
| +27% | +$54.4K |
|
1017
Sanofi
SNY
$104B
| $203K | ﹤0.01% |
4,133
+893
| +28% | +$39.2K |
|
1018
Novartis
NVS
$294B
| $201K | ﹤0.01% |
2,180
+97
| +5% | +$8.17K |
|
|
CVAC
1019
DELISTED
CureVac
CVAC
| $197K | ﹤0.01% |
30,801
+18,689
| +154% | +$138K |
|
|
WSR
1020
DELISTED
Whitestone REIT
WSR
| $196K | ﹤0.01% |
20,240
| – | – |
|
1021
Ocugen
OCGN
$451M
| $195K | ﹤0.01% |
156,111
+43,484
| +39% | +$67.8K |
|
1022
Editas Medicine
EDIT
$455M
| $194K | ﹤0.01% |
22,953
-74
| -0.3% | -$812 |
|
1023
Azenta
AZTA
$1.51B
| $188K | ﹤0.01% |
3,195
+562
| +21% | +$28.8K |
|
1024
Workiva
WK
$3.75B
| $186K | ﹤0.01% |
2,259
-348
| -13% | -$27K |
|
|
NXDT
1025
NexPoint Diversified Real Estate Trust
NXDT
$247M
| $186K | ﹤0.01% |
+16,700
| New | +$212K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Mitsubishi UFJ Asset Management held 1,178 positions worth $36.7B, up 18% from $31.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Mitsubishi UFJ Asset Management deployed $3.46B of net new capital in Q4 2022, opening 48 new positions and adding to 837 existing holdings. Its largest new stake was Ovintiv: 78,884 shares worth $3.71M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amphenol, an estimated $45.4M trimmed.
- Mitsubishi UFJ Asset Management's largest Q4 2022 buy was Ovintiv: 78,884 shares worth $3.71M.
- Mitsubishi UFJ Asset Management added most to Microsoft in Q4 2022, an estimated $236M increase.
- Mitsubishi UFJ Asset Management's biggest Q4 2022 reduction was Amphenol, cutting an estimated $45.4M.
- Mitsubishi UFJ Asset Management fully exited Duke Realty Corp. in Q4 2022, selling an estimated $20.6M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 25% of its $36.7B portfolio in Q4 2022.
- Mitsubishi UFJ Asset Management opened 48 new positions and closed 53 in Q4 2022.
- Mitsubishi UFJ Asset Management's portfolio value rose 18% quarter-over-quarter to $36.7B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.